Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
CEN Case Reports|December 23, 2025
Successful hemodialysis initiation in acquired hemophilia a managed with susoctocog alfa and emicizumabAyano Kihara, Masanori Tamaki, Ryohei Sumitani, et al.Internal Medicine (Tokyo, Japan)|October 6, 2024
Roxadustat for Treating Anemia in Patients with Advanced Chronic Kidney Disease Not Undergoing Dialysis: A Retrospective StudyMasanori Tamaki, Taizo Inagaki, Masanori Minato, et al.Plos One|April 7, 2018
Urinary type IV collagen excretion is involved in the decline in estimated glomerular filtration rate in the Japanese general population without diabetes: A 5-year observational studyFumi Kishi, Kojiro Nagai, Norimichi Takamatsu, et al.The Journal of Medical Investigation : JMI|November 5, 2020
The ADVIA2120i parameter Revised %MICRO is a surrogate marker of schistocyte formation after hematopoietic stem cell transplantationAkishige Ikegame, Yusuke Inoue, Makoto Hata, et al.CEN Case Reports|February 6, 2019
Direct oral anticoagulant successfully used to treat an adult nephrotic patient complicated with portal vein thrombosisFumiaki Obata, Hideharu Abe, Taichi Murakami, et al.BMC Nephrology|August 5, 2017
Successful treatment of highly advanced immunoglobulin G4-related kidney disease presenting renal mass-like regions with end-stage kidney failure: a case studyHiroyuki Ono, Taichi Murakami, Akira Mima, et al.The Journal of Medical Investigation : JMI|October 5, 2018
Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic NephropathyHideharu Abe, Akiko Sakurai, Hiroyuki Ono, et al.Artificial Organs|May 6, 2015
Re-evaluation of Pre-pump Arterial Pressure to Avoid Inadequate Dialysis and Hemolysis: Importance of Prepump Arterial Pressure Monitoring in Hemodialysis PatientsEriko Shibata, Kojiro Nagai, Risa Takeuchi, et al.The Journal of Medical Investigation : JMI|May 9, 2019
The utility and limitation of inferior vena cava diameter as a dry weight markerEriko Shibata, Kojiro Nagai, Sayo Ueda, et al.The Journal of Medical Investigation : JMI|November 5, 2020
Clinical characteristics associated with 1-year tolvaptan efficacy in autosomal dominant polycystic kidney disease with a wide range of kidney functionsTaichi Murakami, Kenji Nishimura, Hiroyuki Ono, et al.Pageof 5